These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33093353)

  • 1. Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major.
    Ordóñez J; Del Cañizo A; Beléndez C; García-Morín M; Pérez-Egido L; Fanjul M; García-Casillas MA; Cerdá J; Peláez D; Bardón E; de Agustín JC; Cela E
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e655-e660. PubMed ID: 33093353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis.
    Nunn JL; Takashima MD; Wray-Jones EM; Soosay Raj TA; Hanna DMT; Ullman AJ
    Support Care Cancer; 2024 Sep; 32(10):662. PubMed ID: 39283363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications.
    Abdul-Rauf A; Gauderer M; Chiarucci K; Berman B
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):342-5. PubMed ID: 7583391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, severity and outcome of central line related complications in pediatric oncology patients; A single center study.
    van den Bosch CH; van der Bruggen JT; Frakking FNJ; Terwisscha van Scheltinga CEJ; van de Ven CP; van Grotel M; Wellens LM; Loeffen YGT; Fiocco M; Wijnen MHWA
    J Pediatr Surg; 2019 Sep; 54(9):1894-1900. PubMed ID: 30415957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central venous access device-related infections in patients with haemophilia.
    Yeoh ZH; Furmedge J; Ekert J; Crameri J; Curtis N; Barnes C
    J Paediatr Child Health; 2013 Mar; 49(3):242-5. PubMed ID: 23438133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and outcome of ultrasound-guided tunneled central venous catheter in children with cancers from low middle-income country: A prospective study.
    Khera S; Kumar A; Parikh B; Simalti AK; Davera S; Mahajan P; Dhingra S
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30029. PubMed ID: 36331108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.
    McCarthy CE; O'Brien M; Andrews J; Zoland JM; Macasiray E; Wong W; Lo C; Glader B; Tamaresis J; Jeng M
    Haemophilia; 2016 Jan; 22(1):81-6. PubMed ID: 26248602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term central venous access in a pediatric leukemia population.
    Fu AB; Hodgman EI; Burkhalter LS; Renkes R; Slone T; Alder AC
    J Surg Res; 2016 Oct; 205(2):419-425. PubMed ID: 27664891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fever at Time of Leukemia Diagnosis in Children: Predictor of Bloodstream Infection or Catheter Removal?
    Barakzai MD; Bozic D; Gupta S; Amirabadi A; Temple M; Chiramel GK; Parra D; Gasparetto A; Amaral JG
    J Vasc Interv Radiol; 2024 May; 35(5):751-758. PubMed ID: 38342222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial.
    Ullman AJ; Kleidon T; Gibson V; McBride CA; Mihala G; Cooke M; Rickard CM
    BMC Cancer; 2017 Aug; 17(1):595. PubMed ID: 28854967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice.
    van den Bosch CH; Spijkerman J; Wijnen MHWA; Hovinga ICLK; Meyer-Wentrup FAG; van der Steeg AFW; van de Wetering MD; Fiocco M; Morsing IE; Beishuizen A
    Support Care Cancer; 2022 Oct; 30(10):8069-8079. PubMed ID: 35776186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Complications Associated With Pediatric Central Venous Access Devices: Prevalence, Incidence, and Risk.
    Ullman AJ; Kleidon TM; Turner K; Gibson V; Dean A; Cattanach P; Pitt C; Woosley J; Marsh N; Gavin N; Takashima M; Rickard CM
    J Pediatr Oncol Nurs; 2019; 36(5):343-351. PubMed ID: 31104548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS).
    Langley AR; Stain AM; Chan A; McLimont M; Chait S; Wu J; Poon MC; Card R; Israels SJ; Laferriere N; Klaassen RJ; Rivard GE; Cloutier S; Hawes S; Feldman B; Blanchette V
    Haemophilia; 2015 Jul; 21(4):469-76. PubMed ID: 26104147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Central Venous Access Device Lock Solutions: A Network Meta-analysis.
    Takashima M; Ezure Y; Furuya-Kanamori L; Wolf J; Dufficy M; Gibson V; Clark J; Ullman A
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38287882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of PORT-A-CATH® in patients with sickle cell disease.
    Alkindi S; Matwani S; Al-Maawali A; Al-Maskari B; Pathare A
    J Infect Public Health; 2012 Mar; 5(1):57-62. PubMed ID: 22341844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric central venous access devices: practice, performance, and costs.
    Ullman AJ; Gibson V; Takashima MD; Kleidon TM; Schults J; Saiyed M; Cattanach P; Paterson R; Cooke M; Rickard CM; Byrnes J; Chopra V
    Pediatr Res; 2022 Nov; 92(5):1381-1390. PubMed ID: 35136199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting mechanical complications of central venous access devices in children.
    Zhang JJ; Nataraja RM; Lynch A; Barnes R; Ferguson P; Pacilli M
    Pediatr Surg Int; 2022 Jul; 38(7):1067-1073. PubMed ID: 35513517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous access devices for paediatric patients with haemophilia: a single-institution experience.
    Titapiwatanakun R; Moir C; Pruthi RK; Stavlo PL; Schmidt KA; Rodriguez V
    Haemophilia; 2009 Jan; 15(1):168-74. PubMed ID: 19149849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repair of central venous access devices in intestinal failure patients is safe and cost-effective: A retrospective single centre cohort study.
    Fletcher J; Woodham D; Cooper SC
    Clin Nutr; 2021 Jun; 40(6):4263-4266. PubMed ID: 33551216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.